Abeona Therapeutics (ABEO) Times Interest Earned (2011 - 2026)
Abeona Therapeutics (ABEO) recorded quarterly Times Interest Earned of -$27.75 in Q1 2026, down 130.1% quarter-over-quarter from $92.2 in Q4 2025, and down 40.39% on a YoY basis from -$46.56 in Q1 2025.
Abeona Therapeutics (ABEO) Times Interest Earned (2011 - 2026) Analysis & Trends
Abeona Therapeutics' Times Interest Earned history runs 15 years deep, the most recent figure standing at -$27.75 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 40.39% year-over-year to -$27.75; the TTM figure through Mar 2026 stood at $3.27 (up 119.96% YoY), while the FY2025 annual figure was $4.0, up 126.23% from the prior year.
- Times Interest Earned was -$27.75 for Q1 2026 at Abeona Therapeutics, down from $92.2 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $92.2 in Q4 2025 to a low of -$121.18 in Q4 2023.
- Historically, Times Interest Earned has averaged -$46.62 across 5 years, with a median of -$27.75 in 2026.
- The sharpest annual moves came in 2022 and 2025: Times Interest Earned slumped 896.57% in 2022, then soared 698.39% in 2025.
- A 5-year view of Times Interest Earned shows it stood at -$72.67 in 2022, then tumbled by 66.75% to -$121.18 in 2023, then surged by 87.28% to -$15.41 in 2024, then jumped by 698.39% to $92.2 in 2025, then plunged by 130.1% to -$27.75 in 2026.
- The last three Times Interest Earned figures came in at -$27.75 (Q1 2026), $92.2 (Q4 2025), and -$26.66 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -258.33 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 11.79 |
| 10 | Abeona Therapeutics | 309.15 Mn | 140.88 Mn | 6.02 Mn | -27.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.75 |
| Dec 31, 2025 | 92.20 |
| Sep 30, 2025 | -26.66 |
| Jun 30, 2025 | -23.82 |
| Mar 31, 2025 | -19.77 |
| Dec 31, 2024 | -15.41 |
| Sep 30, 2024 | -13.92 |
| Jun 30, 2024 | -16.66 |
| Mar 31, 2024 | -15.05 |
| Dec 31, 2023 | -121.18 |
| Sep 30, 2023 | -107.94 |
| Jun 30, 2023 | -102.47 |
| Mar 31, 2023 | -119.19 |
| Dec 31, 2022 | -72.67 |
| Sep 30, 2022 | -59.75 |
| Jun 30, 2022 | -40.04 |
| Mar 31, 2022 | -102.44 |
| Dec 31, 2021 | -880.23 |
| Sep 30, 2021 | -21.77 |
| Jun 30, 2021 | -9.14 |